HEALTHJul 19 · 02:43 UTCDAWN[email protected] (Ikram Junaidi)

Pakistan-China pharma conference ends with $850m agreements

Pakistan and China finalized $850 million in agreements during a pharmaceutical conference, including 16 contracts and 80 MoUs, with 18 deals focused on herbal medicines. The agreements aim to boost local production of health equipment, raw materials, and vaccines, reducing imports and foreign exchange costs.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Pakistan-China Pharmaceutical and Healthcare B2B Investment ConferencetopicMustafa KamalpersonFederal Health MinisterpersonChinese companiesorganizationDrug Regulatory Authority of Pakistanorganizationherbal medicinestopiclocal vaccine productiontopicpharmaceutical raw materialstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

SECURITYJul 17 · 12:02 UTC
Security of Chinese in Pakistan 'paramount for us', says PM Shehbaz
SECURITYJul 18 · 02:32 UTC
Pakistan, China to enhance cooperation on immigration and border management
HEALTHMay 15 · 08:30 UTC
STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
BUSINESSMay 12 · 07:48 UTC
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
HEALTHMay 12 · 18:18 UTC
STAT+: European Union inks a draft deal to boost local production of medicines and avoid shortages
SECURITYJul 16 · 01:59 UTC
Why the West has an uphill task challenging China in pharmaceutical ingredients